Skip to main content
Vericel Corp logo

Vericel Corp — Investor Relations & Filings

Ticker · VCEL ISIN · US92346J1088 LEI · 54930076YM3PLTDR4B91 US Manufacturing
Open in API
Filings indexed 1,130 across all filing types
Latest filing 2026-05-18 Governance Information
Country US United States of America
Listing US VCEL

About Vericel Corp

https://vcel.com/

Vericel Corporation is a biopharmaceutical company that develops, manufactures, and commercializes advanced cell therapies for the sports medicine and severe burn care markets. The company's portfolio is centered on autologous (patient-specific) cell-based products. Key commercial products include MACI® (autologous cultured chondrocytes on porcine collagen membrane), a tissue-engineered product for the repair of symptomatic cartilage defects of the knee, and Epicel® (cultured epidermal autografts), a permanent skin replacement for patients with severe burns. Additionally, Vericel holds the exclusive North American commercial rights for NexoBrid®, a biological orphan product used for the removal of eschar in adults with deep partial-thickness or full-thickness thermal burns.

Recent filings

Filing Released Lang Actions
8-K
Governance Information Classification · 87% confidence The document is a Form 8-K “Current Report” by Vericel Corporation, with Item 5.03 reporting an amendment to the company’s bylaws (Second Amended and Restated Bylaws). This is a change to the company’s internal governance rules and bylaws. Under our taxonomy, such materials fall under 'Governance Information' (CGR).
2026-05-18 English
10-Q - Vericel Corp (0000887359) (Filer)
Interim / Quarterly Report Q1 2026
2026-05-07 English
8-K - Vericel Corp (0000887359) (Filer)
Report Publication Announcement Classification · 90% confidence The document is a Form 8-K current report under Item 2.02 that furnishes a press release announcing first quarter financial results, and expressly states the report “is attached hereto as Exhibit 99.1.” It is short (≈3,700 chars) and contains no substantive financial data itself. Per the “menu vs meal” rule, this is an announcement that a report has been published/attached rather than the report itself, so it should be classified as a Report Publication Announcement (RPA).
2026-05-07 English
8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is an SEC Form 8-K “Current Report” dated April 29, 2026, containing Item 5.07 “Submission of Matters to a Vote of Security Holders.” It provides the detailed voting tallies for director elections, advisory votes on executive compensation, and ratification of the auditor, precisely matching the definition of an announcement of voting results. Therefore, it is classified as a Declaration of Voting Results & Voting Rights Announcement (DVA).
2026-05-01 English
Major Shareholding Notification 2026
Major Shareholding Notification
2026-04-30 English
Major Shareholding Notification 2026
Major Shareholding Notification
2026-04-02 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.